590 Views
Research Conducted in the Digital World Track
2019 AER Conference
Luke Gelinas, PhD
Chairperson, Advarra
Senior Advisor, The Mult-Regional Clinical Trials Center of Brigham & Women's Hospital and Harvard Medical School
Barbara E. Bierer, MD
Faculty Director, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
Professor of Medicine, Harvard Medical School
Laura Odwazny, JD, MA
Senior Attorney, Office of the General Counsel, US DHHS
The widespread use of mobile smart devices and wearables (e.g., smart phones and watches) holds the potential to drastically change how clinical research is conceptualized and conducted. While these developments can make research participation less burdensome and potentially improve participation rates, they raise challenges that IRBs and other stakeholders struggle to navigate. This session will address key ethical and regulatory issues associated with mobile health research. First, the session will describe some common forms of mobile health research, examine its key features and how it differs from more traditional research, and give attendees a sense of its breadth. Second, the session will address regulatory challenges that stem from determining the correct regulatory framework and pathway for mobile applications and wearables, stemming from the IRB's practical need to determine whether a device requires submission to appropriate regulatory authorities before research commences and/or qualifies for a non-significant risk determination. Finally, the session will address the ethical issues that bear on the IRB's device risk determination and overall review of the study. During this session, speakers and attendees will: